Gregory Madison

Gregory Madison

Corporate Officer/Principal bei PROKIDNEY CORP.
59 Jahre
Health Technology
Health Services
Consumer Services

Profil

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Aktive Positionen von Gregory Madison

UnternehmenPositionBeginn
PROKIDNEY CORP. Corporate Officer/Principal 25.03.2026
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 18.06.2021

Ehemalige bekannte Positionen von Gregory Madison

UnternehmenPositionEnde
SHIELD THERAPEUTICS PLC Vorstandsvorsitzender 24.07.2024
KERYX BIOPHARMACEUTICALS Vorstandsvorsitzender 30.04.2018
Direktor/Vorstandsmitglied 30.09.2014
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 07.02.2014
Corporate Officer/Principal 01.01.2012
Sehen Sie sich die Erfahrung von Gregory Madison im Detail an

Ausbildung von Gregory Madison

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

78

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Gregory Madison